Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients

Editorial Material Dermatology

Successful Treatment of Atopic Dermatitis with Dupilumab in a Patient with Non-Hodgkin's Lymphoma

YunMi Qiu et al.

ACTA DERMATO-VENEREOLOGICA (2022)

Add to Collection

Letter Dermatology

Off-label use of dupilumab for the treatment of moderate to severe atopic dermatitis in children aged below 6 years of age: a case series

J. Da et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2022)

Add to Collection

Article Dermatology

Impact on health-related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate-to-severe atopic dermatitis

Marco Miniotti et al.

Summary: This study aims to evaluate the effectiveness of Dupilumab treatment on the health-related quality of life and psychological outcomes of patients with moderate-to-severe atopic dermatitis. The results showed positive improvements in these outcomes up to 32 weeks.

DERMATOLOGIC THERAPY (2022)

Add to Collection

Review Dermatology

Prominent Role of Type 2 Immunity in Skin Diseases-Beyond Atopic Dermatitis

Lina Belmesk et al.

Summary: Type 2 immunity, characterized by Th2 lymphocytes and cytokines, is crucial for host defense and wound healing. Eosinophilia and high IgE counts are hallmarks of type 2 inflammation, which has been extensively studied in skin diseases beyond atopic dermatitis.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2022)

Add to Collection

Article Medicine, General & Internal

Clearance of Chronic Actinic Dermatitis With Dupilumab Therapy in Chinese Patients: A Case Series

Kamran Ali et al.

Summary: In this article, a case series of three patients with severe recalcitrant chronic actinic dermatitis (CAD) is presented, and they showed excellent clinical benefits after being treated with off-label use of dupilumab.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Review Dermatology

Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review

Aleksi J. Hendricks et al.

Summary: Dupilumab has shown efficacy not only in the treatment of atopic dermatitis but also in other chronic skin conditions with overlapping immune signaling pathways, making them potential candidates for therapy when standard treatments fail.

JOURNAL OF DERMATOLOGICAL TREATMENT (2021)

Add to Collection

Letter Dermatology

Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real-life study

Luca Mastorino et al.

DERMATOLOGIC THERAPY (2021)

Add to Collection

Article Dentistry, Oral Surgery & Medicine

Isolated lip dermatitis (atopic cheilitis), successfully treated with topical tacrolimus 0.03%

Eleni Georgakopoulou et al.

Summary: This study retrospectively analyzed 7 cases of atopic eczematous cheilitis affecting only the lips, all of whom were treated with topical tacrolimus and achieved complete response. The findings suggest a potential therapeutic option for this localized form of atopic inflammation affecting the lips.

MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL (2021)

Add to Collection

Review Allergy